Journal: Journal of Molecular and Cellular Cardiology Plus
Article Title: Independent and synergistic roles of MEK-ERK1/2 and PKC pathways in regulating functional changes in vascular tissue following flow cessation
doi: 10.1016/j.jmccpl.2025.100300
Figure Lengend Snippet: Comparison of the effects of the MEK inhibitor Trametinib and PKC inhibitor, RO-317549 to the S6C-mediated contraction of BAs after a 48-h OC . (a) Log concentration-response curves in response to S6c, following incubation with 10 −10 –10 −6 M Trametinib, (b) E max(S6c) responses of BAs incubated with different concentrations of Trametinib, (c) Log concentration-response curves in response to S6c, following incubation with 10 −8 –10 −5 M RO-317549 , (d) E max(S6c) responses of BAs incubated with different concentrations of RO-317549, (e) E max(S6c) responses of BAs incubated with different concentrations of Trametinib, and combination of RO-317549 10 −6 M with different concentrations of Trametinib. The Trametinib curve is the same as shown in panel b. The HillSlope was fixed at −1.727, (f) Representative Sample Traces from LabChart. CTRL refers to BAs incubated for a 48-h in OC with DMSO/Vehicle. Data are shown as mean ± SEM (Biological replicate; n = 5–18). Values were compared with a Student's t -test with a multiple correction (Holm-Sidak). * = p < 0.05.
Article Snippet: The myographs were connected to a PowerLab Unit and responses were sampled in LabChart™ (ADInstruments, UK).
Techniques: Comparison, Concentration Assay, Incubation